FDA Approved: BRIXADI — Original Application (Braeburn Inc.)

View source ↗

Summary

FDA approves BRIXADI (buprenorphine) from Braeburn Inc. under an original application to treat opioid use disorder; BRIXADI is an extended-release injectable fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• BRIXADI (Buprenorphine)

Snippet

ORIG AP for BRIXADI (BUPRENORPHINE)